Cite
HARVARD Citation
Gerthofer, V. et al. (2021). STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. JCO precision oncology. pp. 1507-1513. [Online].